Evidence map›Paper›PMID 34672032›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2021

Late-Stage Amination of Drug-Like Benzoic Acids: Access to Anilines and Drug Conjugates through Directed Iridium-Catalyzed C-H Activation.

Erik Weis, Magnus J Johansson, Belén Martín-Matute

Open access · hybridAbstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Erik WeisDepartment of Organic Chemistry, Stockholm University, 106 91, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7845-4905
Magnus J JohanssonDepartment of Organic Chemistry, Stockholm University, 106 91, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-0904-2835
Belén Martín-MatuteDepartment of Organic Chemistry, Stockholm University, 106 91, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7898-317X
Stockholm University · SE

Funding

Göran Gustafssons Stiftelse för Naturvetenskaplig och Medicinsk ForskningMistra 2018/11Stiftelsen för Strategisk Forskning 16-0041Vetenskapsrådet 2018-03699
6 · The paper itself

Abstract

The functionalization of C-H bonds, ubiquitous in drugs and drug-like molecules, represents an important synthetic strategy with the potential to streamline the drug-discovery process. Late-stage aromatic C-N bond-forming reactions are highly desirable, but despite their significance, accessing aminated analogues through direct and selective amination of C-H bonds remains a challenging goal. The method presented herein enables the amination of a wide array of benzoic acids with high selectivity. The robustness of the system is manifested by the large number of functional groups tolerated, which allowed the amination of a diverse array of marketed drugs and drug-like molecules. Furthermore, the introduction of a synthetic handle enabled expeditious access to targeted drug-delivery conjugates, PROTACs, and probes for chemical biology. This rapid access to valuable analogues, combined with operational simplicity and applicability to high-throughput experimentation has the potential to aid and considerably accelerate drug discovery.

Indexed as

IridiumPharmaceutical PreparationsAminationAniline CompoundsBenzoatesCatalysisAniline CompoundsBenzoatesIridiumPharmaceutical PreparationsaminationC−H activationconjugationhigh-throughput experimentationiridium

Identifiers

PMID34672032
PMCPMC9299223
OpenAlexW3205391401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.